Silicosis is a kind of pneumoconiosis caused by inhalation of silica dust, which is characterized by lung fibrosis. The biologically active form of transforming growth factor-β1 (TGF-β1) plays a key role in the development of lung fibrosis. CD36 is involved in the transformation of latent TGF-β1 (L-TGF-β1) to active TGF-β1. The antagonistic effect of the synthetic peptide was analyzed by the administration of CD36 (93-110) synthetic peptide to the silicosis model of mice. The hydroxyproline content of the silica + CD36 (93-110) synthetic peptide group was significantly lower than that of the other experimental groups [silica and silica + CD36 (208-225) synthetic peptide groups] (p < .05). Inflammation, fibrotic degree and distribution of collagen fibers in silicotic nodules of the silica + CD36 (93-110) synthetic peptide group were less than those of the other experimental groups. The expressions of collagen I and III of the silica + CD36 (93-110) synthetic peptide group were significantly lower than those of the other experimental groups (p < .05). CD36 (93-110) synthetic peptide reduced the tissue fibrotic pathologies and collagen accumulation in the silicosis model of mice, resulting in the decreased severity of silica-induced lung fibrosis.
Abe M., Oda N., Sato Y., Shibata K., and Yamasaki M. ( 2002) Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide. Endothelium9: 25-36.
2.
Azuma A., Li YJ, Abe S., et al. (2005) Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β1 and thrombospondin . American Journal of Respiratory Cell and Molecular Biology32: 93-98.
3.
Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A., and Metcalfe DD ( 2007) Silica-directed mast cell activation is enhanced by scavenger receptors. American Journal of Respiratory Cell and Molecular Biology36: 43-52.
4.
Chen Y., Chen J., Dong J., and Liu W. ( 2005) Antifibrotic effect of Interferon gamma in silicosis model of rat. Toxicology Letters155: 353-360.
5.
Cutroneo KR ( 2006) Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad3 binding to the proximal promoter of the Smad7 gene. Journal of Cell Biochemistry97: 933-939.
6.
Cutroneo KR, White SL, Phan SH, and Ehrlich HP ( 2007) Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. Journal of Cell Physiology211: 585-589.
7.
Daniels CE, Wilkes MC, Edens M., et al. (2004) Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin mediated lung fibrosis. Journal of Clinical Investigation114: 1308-1316.
8.
Dawson DW, Pearce SF, Zhong R., Silverstein RL, Frazier WA, and Bouck NP ( 1997) CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. Journal of Cell Biology138: 707-717.
9.
Febbraio M., Hajjar DP, and Silverstein RL ( 2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. Journal Clinical Investigation108: 785-791.
10.
Gharaee-Kermani M., Ullenbruch M., and Phan SH ( 2005) Animal models of pulmonary fibrosis. Methods in Molecular Medicine117: 251-259.
11.
Hemmati AA, Nazari Z., and Samei M. ( 2008) A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats. Pulmonary Pharmacology & Therapeutics21: 668-674.
12.
Khalil N., Whitman C., Zuo L., Danielpour D., and Greenberg A. ( 1993) Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. Journal of Clinical Investigation92: 1812-1818.
13.
Kolb M., Margetts PJ, Galt T., et al. (2001) Transient trans-gene expression of decorin in the lung reduces the fibrotic response to bleomycin. American Journal of Respiratory and Critical Care Medicine163: 770-777.
14.
Kolb M., Margetts PJ, Sime PJ, and Gauldie J. ( 2001) Proteoglycans decorin and biglycan differentially modulate TGF-β mediated fibrotic responses in the lung. American Journal of Physiology. Lung Cell Molecular Physiology280: L1327-L1334.
15.
Kühlmann UC, Chwieralski CE, van den Brule S., et al. (2009) Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases. Life Sciences84: 1-11.
16.
Leung LL, Li WX, McGregor JL, Albrecht G., and Howard RJ ( 1992) CD36 peptides enhance or inhibit CD36 thrombospondin binding: a two-step process of ligand receptor interaction. Journal of Biological Chemistry267:18244-18250.
17.
Pittet JF, Griffiths MJ, Geiser T., et al. (2001) TGF-beta is a critical mediator of acute lung injury. Journal of Clinical Investigation107: 1537-1544.
18.
Pulichino AM, Wang IM, Caron A., et al. (2008) Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis. American Journal of Respiratory Cell and Molecular Biology39: 324-336.
19.
Venkatesan N., Roughley PJ, and Ludwig MS ( 2002) Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta (1) and interferon gamma. American Journal of Physiology. Lung Cell Molecular Physiology283: L806-814.
20.
Wang Q., Hyde DM, Gotwals PJ, and Giri SN ( 2002) Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters. Experimental Lung Research28: 405-417.
21.
Xu Q., Norman JT, Shrivastav S., Lucio-Cazana J., and Kopp JB ( 2007) In vitro models of TGF-{beta}-induced fibrosis suitable for high-throughput screening of antifibrotic agents. American Journal of Physiology - Renal Physiology293: F631-F640.
22.
Yang YL, Lin SH, Chuang LY, et al. (2007) CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. Journal of Cell Biochemistry101: 735-744.
23.
Yehualaeshet T., O’Connor R., Begleiter A., Murphy-Ullrich JE, Silverstein R., and Khalil N. ( 2000) A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. American Journal of Respiratory Cell and Molecular Biology23: 204-212.
24.
Yehualaeshet T., O’Connor R., Green-Johnson J., et al. (1999) Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. American Journal of Pathology155: 841-851.
25.
Zhou Y., Koli K., Hagood JS, et al. (2009) Latent Transforming Growth Factor-{beta}-binding Protein-4 Regulates Transforming Growth Factor-{beta}1 Bioavailability for Activation by Fibrogenic Lung Fibroblasts in Response to Bleomycin. American Journal of Pathology174: 21-33.
